CoChat
Sign Up
Cited by 12Xenotransplantation and immune responseTissue Engineering and Regenerative MedicineOrgan and Tissue Transplantation Research

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Human Anti-Gal and Anti-Non-Gal Immune Response to Porcine Tissue Implants

Galili, Uri·2015·Host Response to Biomaterials
DOI 10.1016/b978-0-12-800196-7.00010-4
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-800196-7.00010-4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 109

  1. Ansaloni, 2007, Immune response to small intestinal submucosa (surgisis) implant in humans: preliminary observations, J. Invest. Surg., 20, 237, 10.1080/08941930701481296 · DOI
  2. Arenas-Herrera, 2013, Decellularization for whole organ bioengineering, Biomed. Mater., 8, 1, 10.1088/1748-6041/8/1/014106 · DOI · Paper page
  3. Atala, 2009, Engineering organs, Curr. Opin. Biotechnol., 20, 575, 10.1016/j.copbio.2009.10.003 · DOI
  4. Badylak, 2008, Immune response to biologic scaffold materials, Semin. Immunol., 20, 109, 10.1016/j.smim.2007.11.003 · DOI · Paper page
  5. Badylak, 2001, Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix, Exp. Hematol., 29, 1310, 10.1016/S0301-472X(01)00729-9 · DOI
  6. Badylak, 2012, Engineered whole organs and complex tissues, Lancet, 379, 943, 10.1016/S0140-6736(12)60073-7 · DOI · Paper page
  7. Basu, 1973, Enzymatic synthesis of blood group related pentaglycosyl ceramide by an α-galactosyltransferase, J. Biol. Chem., 248, 1700, 10.1016/S0021-9258(19)44247-6 · DOI
  8. Betteridge, 1983, Two α-3-d galactosyltransferases in rabbit stomach mucosa with different acceptor substrate specificities, Eur. J. Biochem., 132, 29, 10.1111/j.1432-1033.1983.tb07321.x · DOI
  9. Blake, 1981, An α-d-galactosyltransferase in Ehrlich ascites tumor cells: Biosynthesis and characterization of a trisaccharide (α-d-galacto(1-3)-N-acetyllactosamine), J. Biol. Chem., 256, 5387, 10.1016/S0021-9258(19)69212-4 · DOI
  10. Blanken, 1985, Biosynthesis of terminal Galα1-3Galß1-4GlcNAc-R oligosaccharide sequence on glycoconjugates: purification and acceptor specificity of a UDP-Gal: N-acetyllactosamine α1,3galactosyltransferase, J. Biol. Chem., 260, 12927, 10.1016/S0021-9258(17)38814-2 · DOI
  11. Britten, 1986, Rates of DNA sequence evolution differ between taxonomic groups, Science, 231, 1393, 10.1126/science.3082006 · DOI · Paper page
  12. Chen, 2010, Extracellular matrix provides an optimal niche for the maintenance and propagation of mesenchymal stem cells, Birth Defects Res., 90, 45, 10.1002/bdrc.20171 · DOI
  13. Chung, 2008, Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose, N. Engl. J. Med., 358, 1109, 10.1056/NEJMoa074943 · DOI · Paper page
  14. Collins, 1994, Cardiac xenografts between primate species provide evidence of the α-galactosyl determinant in hyperacute rejection, J. Immunol., 154, 5500, 10.4049/jimmunol.154.10.5500 · DOI
  15. Commins, 2009, Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-α-1,3-galactose, J. Allergy. Clin. Immunol., 123, 426, 10.1016/j.jaci.2008.10.052 · DOI
  16. Cotterell, 1995, The humoral immune response in humans following cross-perfusion of porcine organs, Transplantation, 60, 861, 10.1097/00007890-199510270-00017 · DOI
  17. Crapo, 2011, An overview of tissue and whole organ decellularization processes, Biomaterials, 32, 3233, 10.1016/j.biomaterials.2011.01.057 · DOI · Paper page
  18. Dabrowski, 1984, Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Determination of branching patterns of a ceramide pentadecasaccharide by 1H nuclear magnetic resonance, J. Biol. Chem., 259, 7648, 10.1016/S0021-9258(17)42840-7 · DOI
  19. Daly, 2009, Effect of the α-Gal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model, Tissue. Eng. Part. A., 15, 3877, 10.1089/ten.tea.2009.0089 · DOI
  20. Decaris, 2011, Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation, Ann. Biomed. Eng., 39, 1174, 10.1007/s10439-010-0217-x · DOI
  21. Dittrich, 2000, Comparison of porcine xenografts and homografts for pulmonary valve replacement in children, Ann. Thorac. Surg., 70, 717, 10.1016/S0003-4975(00)01532-0 · DOI
  22. Egge, 1985, Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes, J. Biol. Chem., 260, 4927, 10.1016/S0021-9258(18)89161-X · DOI
  23. Eto, 1968, Chemistry of lipids of the posthemolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes in rabbit, J. Biochem. (Tokyo), 64, 205, 10.1093/oxfordjournals.jbchem.a128881 · DOI
  24. Galili, 1993, Evolution and pathophysiology of the human natural anti-Gal antibody, Springer. Semin. Immunopathol., 15, 155, 10.1007/BF00201098 · DOI
  25. Galili, 2012, Induced anti-non gal antibodies in human xenograft recipients, Transplantation, 93, 11, 10.1097/TP.0b013e31823be870 · DOI
  26. Galili, 2013, Anti-Gal: An abundant human natural antibody of multiple pathogeneses and clinical benefits, Immunology, 140, 1, 10.1111/imm.12110 · DOI · Paper page
  27. Galili, 2013, Anti-Gal macrophage recruitment and activation by α-gal nanoparticles accelerate regeneration and can improve biomaterials efficacy in tissue engineering, Open Tissue Eng. Regen. Med. J., 6, 1, 10.2174/1875043501306010001 · DOI
  28. Galili, 2013, α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates, Xenotransplantation, 20, 267, 10.1111/xen.12051 · DOI
  29. Galili, 1991, Gene sequences suggest inactivation of α1-3 galactosyltransferase in catarrhines after the divergence of apes from monkeys, Proc. Natl. Acad. Sci. USA, 88, 7401, 10.1073/pnas.88.16.7401 · DOI
  30. Galili, 1995, Suppression of α-galactosyl epitopes synthesis and production of the natural anti-Gal antibody: A major evolutionary event in ancestral Old World primates, J. Human Evol., 29, 433, 10.1006/jhev.1995.1067 · DOI
  31. Galili, 1984, A unique natural human IgG antibody with anti-α-galactosyl specificity, J. Exp. Med., 160, 1519, 10.1084/jem.160.5.1519 · DOI · Paper page
  32. Galili, 1985, Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3)-linked galactose residues, J. Exp. Med., 162, 573, 10.1084/jem.162.2.573 · DOI
  33. Galili, 1987, Evolutionary relationship between the anti-Gal antibody and the Galα1→3Gal epitope in primates, Proc. Natl. Acad. Sci. USA, 84, 1369, 10.1073/pnas.84.5.1369 · DOI
  34. Galili, 1988, Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora, Infect. Immun., 56, 1730, 10.1128/IAI.56.7.1730-1737.1988 · DOI
  35. Galili, 1988, Man, apes, and Old World monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells, J. Biol. Chem., 263, 17755, 10.1016/S0021-9258(19)77900-9 · DOI · Paper page
  36. Galili, 1993, One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody, Blood, 82, 2485, 10.1182/blood.V82.8.2485.2485 · DOI
  37. Galili, 1995, Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters, Transplantation, 59, 1549, 10.1097/00007890-199506150-00008 · DOI
  38. Galili, 1997, Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection, Transplantation, 63, 646, 10.1097/00007890-199703150-00006 · DOI
  39. Galili, 1998, A sensitive assay for measuring α-gal epitope expression on cells by a monoclonal anti-Gal antibody, Transplantation, 65, 1129, 10.1097/00007890-199804270-00020 · DOI
  40. Galili, 2001, Induced antibody response in xenograft recipients, GRAFT, 4, 32, 10.1177/152216280100400108 · DOI
  41. Galili, 2007, Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines, J. Immunol., 178, 4676, 10.4049/jimmunol.178.7.4676 · DOI
  42. Galili, 2010, Accelerated healing of skin burns by anti-Gal/α-gal liposomes interaction, BURNS, 36, 239, 10.1016/j.burns.2009.04.002 · DOI
  43. Gonzalez-Andrades, 2011, Generation of bioengineered corneas with decellularized xenografts and human keratocytes, Invest. Ophthalmol. Vis. Sci., 52, 215, 10.1167/iovs.09-4773 · DOI
  44. Groth, 1994, Transplantation of porcine fetal pancreas to diabetic patients, Lancet, 344, 1402, 10.1016/S0140-6736(94)90570-3 · DOI
  45. Guilak, 2009, Control of stem cell fate by physical interactions with the extracellular matrix, Cell. Stem. Cell., 5, 17, 10.1016/j.stem.2009.06.016 · DOI
  46. Hamadeh, 1995, Human secretions contain IgA, IgG and IgM anti-Gal (anti-α-galactosyl) antibodies, Clin. Diagnos Lab Immunol., 2, 125, 10.1128/CDLI.2.2.125-131.1995 · DOI
  47. Hidalgo-Bastida, 2010, Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering, Tissue. Eng. Part. B. Rev., 16, 405, 10.1089/ten.teb.2009.0714 · DOI
  48. Hiles, 2009, Are biologic grafts effective for hernia repair? A systematic review of the literature, Surg. Innov., 16, 26, 10.1177/1553350609331397 · DOI
  49. Hurwitz, 2012, Accelerated porcine wound healing with α-Gal nanoparticles, Plast. Reconst. Surgery., 129, 242, 10.1097/PRS.0b013e31823aebb1 · DOI
  50. Joziasse, 1991, Characterization of an α1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene, J. Biol. Chem., 266, 6991, 10.1016/S0021-9258(20)89600-8 · DOI
  51. Jung, 2005, Cell-to-cell contact is critical for the survival of hematopoietic progenitor cells on osteoblasts, Cytokine, 32, 155, 10.1016/j.cyto.2005.09.001 · DOI
  52. Kasimir, 2005, Presence and elimination of the xenoantigen gal (α1, 3) gal in tissue-engineered heart valves, Tissue Eng., 11, 1274, 10.1089/ten.2005.11.1274 · DOI
  53. Klos, 2013, International Union of Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors, Pharmacol. Rev., 65, 500, 10.1124/pr.111.005223 · DOI
  54. Koike, 2002, Molecular basis of evolutionary loss of the α1,3-galactosyltransferase gene in higher primates, J. Biol. Chem., 277, 10114, 10.1074/jbc.M110527200 · DOI
  55. Koike, 2007, Functionally important glycosyltransferase gain and loss during catarrhine primate emergence, Proc. Natl. Acad. Sci. USA, 104, 559, 10.1073/pnas.0610012104 · DOI
  56. Konakci, 2005, α-Gal on bioprosthesis: xenograft immune response in cardiac surgery, Eur. J. Clin. Invest., 35, 17, 10.1111/j.1365-2362.2005.01441.x · DOI
  57. Lai, 2002, Production of α-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning, Science, 295, 1089, 10.1126/science.1068228 · DOI
  58. Lantéri, 2002, A complete α1,3-galactosyltransferase gene is present in the human genome and partially transcribed, Glycobiology, 12, 785, 10.1093/glycob/cwf087 · DOI
  59. Larsen, 1990, Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Galß-d-Gal(1,4)-d-GlcNAcα(1,3) galactosyltransferase cDNA, J. Biol. Chem., 265, 7055, 10.1016/S0021-9258(19)39258-0 · DOI
  60. Li, 2004, Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells, Endothelium, 11, 199, 10.1080/10623320490512390 · DOI
  61. Lolmede, 2009, Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways, J. Leukoc. Biol., 85, 779, 10.1189/jlb.0908579 · DOI · Paper page
  62. Manji, 2014, Bioprosthetic heart valves of the future, Xenotransplantation, 21, 1, 10.1111/xen.12080 · DOI
  63. Mantovani, 2013, Macrophage plasticity and polarization in tissue repair and remodelling, J. Pathol., 229, 176, 10.1002/path.4133 · DOI · Paper page
  64. Maruyama, 1999, Interaction of baboon anti-α-galactosyl antibody with pig tissues, Am. J. Pathol., 155, 1635, 10.1016/S0002-9440(10)65479-X · DOI
  65. Maruyama, 1999, α-Galactosyl antibody redistributes α-galactosyl at the surface of pig blood and endothelial cells, Transpl. Immunol., 7, 101, 10.1016/S0966-3274(99)80026-4 · DOI
  66. Maruyama, 2000, α-Galactosyl epitopes on glycoproteins of porcine renal extracellular matrix, Kidney. Int., 57, 655
  67. McGregor, 2013, Gal-knockout bioprostheses exhibit less immune stimulation compared to standard biological heart valves, J. Heart Valve Dis., 22, 383
  68. McPherson, 1998, Characterization of fibronectin derived from porcine small intestinal submucosa, Tiss. Eng., 4, 75, 10.1089/ten.1998.4.75 · DOI
  69. McPherson, 2000, Galα(1,3)Gal epitope in porcine small intestinal submucosa, Tissue Eng., 6, 233, 10.1089/10763270050044416 · DOI
  70. Mohan, 1986, Macromolecular organization of basement membranes. Characterization and comparison of glomerular basement membrane and lens capsule components by immunochemical and lectin affinity procedures, J. Biol. Chem., 261, 4328, 10.1016/S0021-9258(17)35665-X · DOI
  71. Morisset, 2012, Anaphylaxis to pork kidney is related to IgE antibodies specific for galactose-α-1,3-galactose, Allergy, 67, 699, 10.1111/j.1398-9995.2012.02799.x · DOI
  72. Naso, 2013, First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses, Xenotransplantation, 20, 252, 10.1111/xen.12044 · DOI
  73. Ogawa, 2006, Profiling terminal N-acetyllactoamines of glycans on mammalian cells by an immuno-enzymatic assay, Glycoconj. J., 23, 663, 10.1007/s10719-006-9005-0 · DOI
  74. Park, 2009, Removal of α-Gal epitopes from porcine aortic valve and pericardium using recombinant human α-galactosidase A, J. Korean. Med. Sci., 24, 1126, 10.3346/jkms.2009.24.6.1126 · DOI
  75. Parker, 1999, Naturally occurring anti-α-galactosyl antibodies: relationship to xenoreactive anti-α-galactosyl antibodies, Glycobiology, 9, 865, 10.1093/glycob/9.9.865 · DOI
  76. Phelps, 2003, Production of α1,3-galactosyltransferase-deficient pigs, Science, 299, 411, 10.1126/science.1078942 · DOI
  77. Purinya, 1994, Biomechanical and structural properties of the explanted bioprosthetic valve leaflets, J. Biomech., 27, 1, 10.1016/0021-9290(94)90027-2 · DOI
  78. Raeder, 2002, Natural anti-galactose α1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts, Transpl. Immunol., 10, 15, 10.1016/S0966-3274(01)00044-2 · DOI
  79. Ravetch, 2001, IgG Fc receptors, Annu. Rev. Immunol., 19, 275, 10.1146/annurev.immunol.19.1.275 · DOI
  80. Sarich, 1967, Rates of albumin evolution in primates, Proc. Natl. Acad. Sci. USA, 58, 142, 10.1073/pnas.58.1.142 · DOI
  81. Selvaraj, 2004, Functional regulation of human neutrophil Fc gamma receptors, Immunol. Res., 29, 219, 10.1385/IR:29:1-3:219 · DOI
  82. Shakibaei, 1998, Inhibition of chondrogenesis by integrin antibody in vitro, Exp. Cell. Res., 240, 95, 10.1006/excr.1998.3933 · DOI
  83. Simon, 1998, Intravenous infusion of Galα1-3Gal oligosaccharides in baboon delays hyperacute rejection of porcine heart xenografts, Transplantation, 56, 346, 10.1097/00007890-199802150-00009 · DOI
  84. Smith, 1990, Transfer and expression of a murine UDP-Gal:β-d-Gal-α1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the α1,3-galactosyltransferase and the endogenous α2,3-sialyltransferase, J. Biol. Chem., 265, 6225, 10.1016/S0021-9258(19)39314-7 · DOI
  85. Spiro, 1984, Occurrence of α-d-galactosyl residues in the thyroglobulin from several species. Localization in the saccharide chains of the complex carbohydrate units, J. Biol. Chem., 259, 9858, 10.1016/S0021-9258(17)42779-7 · DOI
  86. Stellner, 1973, Determination of aminosugar linkage in glycolipids by methylation. Aminosugar linkage of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen, Arch. Biochem. Biophys., 133, 464, 10.1016/0003-9861(73)90138-0 · DOI
  87. Stone, 1997, Porcine and bovine cartilage transplants in cynomolgus monkey: I. A model for chronic xenograft rejection, Transplantation, 63, 640, 10.1097/00007890-199703150-00005 · DOI
  88. Stone, 1998, Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of α-galactosidase-treated porcine cartilage, Transplantation, 65, 1577, 10.1097/00007890-199806270-00007 · DOI
  89. Stone, 2007, Anterior cruciate ligament reconstruction with a porcine xenograft: a serologic, histologic, and biomechanical study in primates, Arthroscopy, 23, 411, 10.1016/j.arthro.2006.12.024 · DOI
  90. Stone, 2007, Replacement of human anterior cruciate ligaments with pig ligaments: a model for anti-non-gal antibody response in long-term xenotransplantation, Transplantation, 83, 211, 10.1097/01.tp.0000250598.29377.13 · DOI
  91. Takahagi, 2005, Production of α1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III, Mol. Reprod. Dev., 71, 331, 10.1002/mrd.20305 · DOI
  92. Takahashi, 2014, Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef, Allergy, 69, 199, 10.1111/all.12302 · DOI
  93. Tanemura, 2000, Differential expression of α-gal epitopes (Galα1-3Galß1-4GlcNAc-R) on pig and mouse organs, Transplantation, 69, 187, 10.1097/00007890-200001150-00034 · DOI
  94. Tanemura, 2000, Differential immune response to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation, J. Clin. Invest., 105, 301, 10.1172/JCI7358 · DOI
  95. Tearle, 1996, The α-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation, Transplantation, 61, 13, 10.1097/00007890-199601150-00004 · DOI
  96. Teranishi, 2002, Anti-Gal α1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates, Xenotransplantation, 9, 48, 10.1034/j.1399-3089.2002.1o058.x · DOI
  97. Thall, 1990, Distribution of Gal α1-3Galβ1-4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay, Biochemistry, 29, 3959, 10.1021/bi00468a024 · DOI
  98. Thall, 1991, The α-galactosyl epitope on mammalian thyroid cells, Acta Endocrinol., 124, 692, 10.1530/acta.0.1240692 · DOI
  99. Wang, 1995, Human anti-Gal heavy chain genes: preferential use of VH3 and the presence of somatic mutations, J. Immunol., 155, 1276, 10.4049/jimmunol.155.3.1276 · DOI
  100. Wigglesworth, 2011, Rapid recruitment and activation of macrophages by anti-Gal/α-gal liposome interaction accelerates wound healing, J. Immunol., 186, 4422, 10.4049/jimmunol.1002324 · DOI
  101. Williams, 1991, Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions, Nature, 352, 438, 10.1038/352438a0 · DOI
  102. Wilson, 1985, The molecular basis of evolution, Sci. Am., 253, 164, 10.1038/scientificamerican1085-164 · DOI
  103. Xu, 1998, Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4Glc-R immunoaffinity column, Transplantation, 65, 172, 10.1097/00007890-199801270-00005 · DOI
  104. Yang, 2010, In vitro evaluation of the bioactive factors preserved in porcine small intestinal submucosa through cellular biological approaches, J. Biomed. Mater. Res. A., 93, 1100, 10.1002/jbm.a.32534 · DOI
  105. Yano, 2006, Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair, J. Am. Coll. Cardiol., 626, 10.1016/j.jacc.2005.09.037 · DOI
  106. Yu, 1999, Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues, J. Clin. Immunol., 19, 116, 10.1023/A:1020506617105 · DOI
  107. Zhang, 2009, Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype, Biomaterials, 30, 4021, 10.1016/j.biomaterials.2009.04.005 · DOI · Paper page
  108. Zhu, 1995, High-level expression and purification of coffee bean alpha-galactosidase produced in the yeast Pichia pastoris, Arch. Biochem. Biophys., 324, 65, 10.1006/abbi.1995.9928 · DOI
  109. Zhu, 1996, Characterization of recombinant alpha-galactosidase for use in seroconversion from blood group B to O of human erythrocytes, Arch. Biochem. Biophys., 327, 324, 10.1006/abbi.1996.0129 · DOI

Cited by

Sorted by citations

Metadata

Authors
Galili, U.
Affiliations
University of Massachusetts Chan Medical School (US)
Corresponding author
Galili, Uri
ORCID
Galili, Uri
Venue
Host Response to Biomaterials
Publisher
Elsevier
Published
2015
Pages
239-267
DOI
10.1016/b978-0-12-800196-7.00010-4
OpenAlex
W2477705402
Cited by
12
References
2
Citations by year
2024: 3 · 2023: 5 · 2022: 1 · 2021: 1 · 2017: 2
FWCI
9.51
Type
book chapter
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Elsevier eBooks (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
Keywords
anti-Gal antibodies, xenotransplantation, alpha-gal epitope, alpha-galactosidase, complement activation, macrophage recruitment, stem cell recruitment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review